An interventional study of Video polysomnography in REM Sleep Behavior Disorder and Parkinson's Disease, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 45 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Prevention
Figorilli M, Marques AR, Vidal T, Delaby L, Meloni M, Pereira B, Lambert C, Puligheddu M, Durif F, Fantini ML. Does REM sleep behavior disorder change in the p…PubMed 32044557 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in REM Sleep Behavior Disorder with a site in France — 6 open to participants now, 6 under way, none of them phase 3. REM Sleep Behavior Disorder · France.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, this one is the 8th largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2017, is one of 10 with no phase, and was the 3rd registered.
101 studies on the registry are indexed under REM Sleep Behavior Disorder; 45 are open to participants now.
Browse REM Sleep Behavior Disorder studies →6 of the 15 studies in REM Sleep Behavior Disorder with a site in France are open now. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 45–80
University Hospital, Toulouse · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
Queen Mary University of London · Sites in France, Spain, United Kingdom
Ages 50+
University Hospital, Toulouse · Sites in France, Germany, Spain and 1 more country
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 32 REM Sleep Behavior Disorder studies recruiting now, 18 (56%) set no upper age limit and 4 (13%) stop at 75 or younger; 4 take children under 18; 17 take healthy volunteers.
This study: 45 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 3 started in 2017.
This study's enrollment of 24 is below the median of 42 across 50 interventional studies indexed under REM Sleep Behavior Disorder.
Median enrollment 54 across the 10 interventional studies, 60 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 9 most frequent:
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
University Hospital, Clermont-Ferrand has 6 studies filed under REM Sleep Behavior Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in REM Sleep Behavior Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07706829Queen Mary University of LondonArtificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study | 2027-09-30 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
About 60% of Parkinson's Disease (PD) patients have REM sleep Behavior Disorder (RBD), a parasomnia characterized by partial or complete loss of REM sleep muscle atonia and dream-enacting behaviors, usually associated to vivid dreams. The REM Sleep without atonia is the polysomnographic hallmark of RBD, and its quantification is necessary for the diagnosis.
RBD in PD is believed to be a marker of a more widespread degenerative process and a marker of malignant phenotype. Therefore, PD patients with RBD (PD-RBD) are more severely impaired in both motor and non-motor domains, compared to those without RBD, with an increased risk of dementia. However, little is know about the relationship between the evolution of RBD, clinic and video-polysomnographic, and the progression of PD. Besides, an improvement of RBD symptoms is anecdotally reported in PD patients over time. Longitudinal evaluation of RBD in PD, assessed by questionnaires, led to controversial results, but so far, no longitudinal vPSG study has been performed in PD-RBD population.
Thus, the main objective of this study is to longitudinally evaluate clinical and video-polysomnographic features of RBD, including measure of REM Sleep without atonia, in patients with PD-RBD, after three years from the diagnosis of RBD, in order to ascertain whether RBD features remain stable over time. The possible remission of RBD with the progression of PD would question indeed its reliability as prognostic bio-marker.
Type of study: longitudinal study, interventional, cross-sectional;
Number of centres: 1 (Clermont-Ferrand)
Patients: patients with Parkinson's Disease associated with REM sleep behavior disorder (PD-RBD) having already underwent video-polysomnography recording, clinical and neuropsychological evaluation in clinical setting or in the study "RBHP 2013 DURIF " at least three years ago.
Study performance:
This study will be developed in two phases:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
patients with PD-RBD having already underwent vPSG, clinical and neuropsychological in clinical setting or in the study "RBHP 2013 DURIF " at least three years ago.
Procedure: Video polysomnography
the main objective of our study is to longitudinally evaluate clinical and vPSG features of RBD, including measure of RSWA, in patients with PD-RBD, after three years from the diagnosis of RBD, in order to ascertain whether RBD features remain stable over time. The possible remission of RBD with the progression of PD would question indeed its reliability as prognostic bio-marker.
presence of REM sleep Behavior Disorder confirmed during the video polysomnography
Time frame: at day 0
The REM sleep Behavior Disorder severity measured by the REM sleep Behavior Disorder scale
Time frame: at day 0
The Unified Parkinson disease Rating scale score
Time frame: at day 0
The behavioral disorders measured by the Ardouin Scale of Behavior in Parkinson's Disease score
Time frame: at day 0
- The Orthostatic hypotension measured by the Scale for outcomes in PD- autonomic questionnaire
Time frame: at day 0
The impulsivity measured by the Test of Kirby score
Time frame: at day 0
The impulsivity measured by the Stop signal reaction time score
Time frame: at day 0
The Hoehn and Yahr scale score
Time frame: at day 0
The Non-motor symptoms Questionnaire score
Time frame: at day 0
The Epworth sleepiness scale score
Time frame: at day 0
The Urgency premeditation perseverance and sensation seeking test
Time frame: at day 0
The Aggressive questionnaire score
Time frame: at day 0
The Hospital Anxiety and Depression Rating Scale
Time frame: at day 0
The dream content
Time frame: at day 0
The Mini mental state examination score
Time frame: at day 1
The California Verbal Learning Test score
Time frame: at day 1
The fluency verbal test score
Time frame: at day 1
The Modified Wisconsin Card Sorting Test
Time frame: at day 1
The Stroop score
Time frame: at day 1
The Empan test score
Time frame: at day 1
The Visual Object and Space Perception Battery test score
Time frame: at day 1
The Luria motor sequences
Time frame: at day 1
The Rey-Osterrieth complex figure
Time frame: at day 1
The Lille Apathy Rating Scale score
Time frame: at day 1
The Iowa Gambling test score
Time frame: at day 1
Ran from Feb 2017 to primary completion in Sep 2018, 18 months.
Primary completion moved once since we started tracking on Sep 25, 2026: Apr 2019 → Sep 2018, on Nov 10, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Figorilli M, Marques AR, Vidal T, Delaby L, Meloni M, Pereira B, Lambert C, Puligheddu M, Durif F, Fantini ML. Does REM sleep behavior disorder change in the p…PubMed 32044557 ↗
Figorilli M, Marques AR, Vidal T, Delaby L, Meloni M, Pereira B, Lambert C, Puligheddu M, Durif F, Fantini ML. Does REM sleep behavior disorder change in the p…PubMed 32044557 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →